A First Time in Human Study of GSK586529 in Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
A single blind, randomized, placebo-controlled, crossover study in twenty four healthy male subjects. Subjects will be divided into two cohorts with alternate panel design. The study is investigating the safety, tolerability and pharmacokinetics of single oral escalating doses of GSK586529.
Epistemonikos ID: ac5d146f1556d1234260f8340898a3a99def84fc
First added on: May 05, 2024